Shares of Calyxt Inc (NASDAQ: CLXT) gained more than 7 percent Monday after analysts at BMO Capital Markets initiated coverage of the food and agriculture company with a bullish rating. The firm s Kenneth Zaslow slapped an Outperform rating on Calyxt s stock with a $32 price target.
Calyxt is. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Search jobs Global Infectious Disease Drug Market 2021-2026 Study & Future Prospects Including key players Profiles
Data Bridge Market Research Adds “Global Infectious Disease Drug Market– Industry Trends and Forecast to 2028” new report to its research database. The report spread No of pages : 350 No of Figures: 60 No of Tables: 220 in it. This comprehensive Global Infectious Disease Drug Market industry research report includes a brief on these trends that can help the organizations operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market CAGR,Volume, industry share And size, demand and trend growth, key segments, and key drivers and restrains.
Data Bridge Market Research recently added “
Smart Diabetes Management Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Smart Diabetes Management Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Global Smart Diabetes Management Market By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed Loop Systems), Devices Type (Handheld Devices, Wearable Devices), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Diabetes Type (Type 1 Diabetes, Type 2 Diabetes), End Use (Home Healt
Top 10 Large-Cap Healthcare Stocks to Buy Now
The healthcare industry has been one of the strongest drivers of GDP growth in recent decades, which has translated into massive returns for healthcare stocks. The healthcare sector’s total return of 296% during the 2010’s only trailed two other sectors, technology and consumer discretionary.
Some of the biggest winners during the decade were managed care providers and health insurers, which rode the Affordable Care Act to massive returns. Biotech and medical device companies were also strong performers.
That trend is expected to continue in the decades to come, with health spending projected to outpace GDP growth in the majority of OECD countries over the next decade, resulting in health spending per capita reaching an estimated 10.2% of GDP by 2030, up from 8.8% in 2018. In the U.S, the Centers for Medicare and Medicaid Services Office of the Actuary projects that healthcare will account for 19.4% of GDP in 2027, up from 17.9% in
An Aging Population is Increasing the Need for Novel Treatments
FN Media Group Presents Microsmallcap.com Market Commentary
News provided by
Share this article
Share this article
NEW YORK, Feb. 3, 2021 /PRNewswire/ With the onset of a world health crisis, our seniors are at a greater risk than they were a decade ago. In addition, the growing senior population has tripled in size over the past 40 years. The elderly are at a higher risk of contracting diseases such as cancers, Parkinson s, diabetes, and arthritis, which has led to increased rates of these diseases. Fortunately, with the assistance of pharmaceutical companies, this vulnerable population can seek protection against such diseases. Pharmaceutical companies involved in products to help this aging population include